DCGI has sought post-market surveillance data from the drugmakers of two fixed-dose combination medicines—Imipramine Hydrochloride IP + Diazepam IP tablets used to ease co-morbid anxiety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback